FDA Warning Letter — Surmasis Pharmaceutical, LLC
The FDA took a Warning Letter action against Surmasis Pharmaceutical, LLC on November 6, 2018 (Des Moines, IA). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Surmasis Pharmaceutical, LLC
- Date
- November 6, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Des Moines, IA (United States)